Lv614
2210 积分 2024-04-16 加入
Economic impact of a faricimab vial‐sharing protocol in age‐related macular degeneration and diabetic macular oedema patients
23天前
已完结
Patient-Centered Economic Burden of Diabetic Macular Edema: Retrospective Cohort Study (Preprint)
23天前
已完结
Quantifying cost-savings in the treatment of neovascular age-related macular degeneration in Aotearoa New Zealand
23天前
已关闭
Pharmacoeconomic analysis of anti-angiogenic drugs for diabetic macular edema
23天前
已关闭
Cost-Utility Analysis of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
1个月前
已关闭
Cost-Utility Analysis of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
1个月前
已关闭
Cost-effectiveness analysis of bispecific antibody faricimab for treatment of neovascular age-related macular degeneration and diabetic macular edema in Japan
1个月前
已完结
AI Can Improve the Economics of Blindness Prevention in Canada
1个月前
已完结
Deep learning
1个月前
已完结
Comparative efficacy of ligelizumab versus omalizumab in chronic spontaneous urticaria
1个月前
已完结
皖公网安备34019202002308
